Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada.
DISCERN
Healthcare professionals
Herbal
Kratom
Mitragyna speciosa
Natural health products
Online vendor
Journal
Substance abuse treatment, prevention, and policy
ISSN: 1747-597X
Titre abrégé: Subst Abuse Treat Prev Policy
Pays: England
ID NLM: 101258060
Informations de publication
Date de publication:
19 03 2021
19 03 2021
Historique:
accepted:
04
03
2021
entrez:
20
3
2021
pubmed:
21
3
2021
medline:
23
11
2021
Statut:
epublish
Résumé
Amid a Canadian opioid crisis, many have turned to natural health products, such as kratom (Mitragyna speciosa), to manage their opioid withdrawal. Kratom has also been reported to relieve anxiety, improve stamina, and heighten physical performance. Given that kratom is not authorized for sale by Health Canada, many have turned to online retailers to purchase kratom due to its easy accessibility online. This study investigated the quality of consumer health information provided on the websites of online vendors selling kratom to consumers in Canada. Following searches on Google.ca using search terms designed to simulate the information-seeking behaviour of a typical patient-user online, eligible websites were assessed using the 16-question DISCERN instrument, a tool designed to assess the quality of consumer health information. Searches were conducted on March 27, 2020 and only websites presenting information in English were included. A total of 200 webpages were identified; after screening based on eligibility criteria and combining different webpages that belonged to the same website, 51 websites were found to be eligible. The mean summed DISCERN score across all 51 websites was 36.95 (SD = 2.44) out of 75, which reflects poor quality consumer health information across the subset of websites. The overall quality of websites was poor, as 78% (n = 40) of vendors received a score of 2 or less out of 5. Individuals who seek information about kratom online are frequently exposed to poor quality consumer health information. Those looking to purchase kratom online are not provided with the critical information necessary to make an informed decision regarding its use, such as the complete details about the risks and side effects or a description of how kratom affects the body. Given the growing interest in kratom, knowledge of the quality of information available can lead to improved dialogue between healthcare providers and patients.
Sections du résumé
BACKGROUND
Amid a Canadian opioid crisis, many have turned to natural health products, such as kratom (Mitragyna speciosa), to manage their opioid withdrawal. Kratom has also been reported to relieve anxiety, improve stamina, and heighten physical performance. Given that kratom is not authorized for sale by Health Canada, many have turned to online retailers to purchase kratom due to its easy accessibility online. This study investigated the quality of consumer health information provided on the websites of online vendors selling kratom to consumers in Canada.
METHODS
Following searches on Google.ca using search terms designed to simulate the information-seeking behaviour of a typical patient-user online, eligible websites were assessed using the 16-question DISCERN instrument, a tool designed to assess the quality of consumer health information. Searches were conducted on March 27, 2020 and only websites presenting information in English were included.
RESULTS
A total of 200 webpages were identified; after screening based on eligibility criteria and combining different webpages that belonged to the same website, 51 websites were found to be eligible. The mean summed DISCERN score across all 51 websites was 36.95 (SD = 2.44) out of 75, which reflects poor quality consumer health information across the subset of websites. The overall quality of websites was poor, as 78% (n = 40) of vendors received a score of 2 or less out of 5.
CONCLUSIONS
Individuals who seek information about kratom online are frequently exposed to poor quality consumer health information. Those looking to purchase kratom online are not provided with the critical information necessary to make an informed decision regarding its use, such as the complete details about the risks and side effects or a description of how kratom affects the body. Given the growing interest in kratom, knowledge of the quality of information available can lead to improved dialogue between healthcare providers and patients.
Identifiants
pubmed: 33741009
doi: 10.1186/s13011-021-00361-2
pii: 10.1186/s13011-021-00361-2
pmc: PMC7977165
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
23Références
J Am Chem Soc. 2016 Jun 1;138(21):6754-64
pubmed: 27192616
BMC Complement Altern Med. 2008 Jul 14;8:40
pubmed: 18625059
Maturitas. 2016 Jun;88:16-22
pubmed: 27105691
Bull Narc. 1974 Apr-Jun;26(2):41-55
pubmed: 4607551
MMWR Morb Mortal Wkly Rep. 2019 Apr 12;68(14):326-327
pubmed: 30973850
J Anal Toxicol. 2011 Jan;35(1):54-9
pubmed: 21219704
J Psychopharmacol. 2019 Sep;33(9):1102-1123
pubmed: 31429622
Can Fam Physician. 2014 May;60(5):407-8
pubmed: 24828994
J Psychoactive Drugs. 2018 Nov-Dec;50(5):445-450
pubmed: 30152738
Front Psychiatry. 2017 Apr 24;8:62
pubmed: 28484399
Subst Abuse Rehabil. 2019 Jul 01;10:23-31
pubmed: 31308789
J Psychoactive Drugs. 2019 Jan-Mar;51(1):12-18
pubmed: 30614408
Adv Rheumatol. 2021 Jan 19;61(1):6
pubmed: 33468233
Neuropharmacology. 2018 May 15;134(Pt A):108-120
pubmed: 28830758
J Med Toxicol. 2016 Dec;12(4):341-349
pubmed: 27752985
Forensic Sci Int. 2017 Feb;271:e1-e7
pubmed: 28089300
Complement Ther Med. 2021 Jan 27;57:102674
pubmed: 33515681
J Med Chem. 2016 Sep 22;59(18):8381-97
pubmed: 27556704
Drug Alcohol Depend. 2020 Mar 1;208:107849
pubmed: 32029298
A A Pract. 2018 Apr 15;10(8):192-194
pubmed: 29652682
ACS Pharmacol Transl Sci. 2020 Jul 31;3(6):1063-1068
pubmed: 33344889
Drug Alcohol Depend. 2018 Feb 1;183:134-140
pubmed: 29248691
Eur J Pharmacol. 1996 Dec 12;317(1):75-81
pubmed: 8982722